Here’s an article about three French doctors treating COVID-19 patients with a combination of azithromycin and zinc.
“Inspired by Previous work on the combination of hydrochloroquine and azithromycin, three doctors practicing in the Moselle in northern France have tested a new treatment on hundreds of patients. Not able to prescribe chloroquine which can only be prescribed in hospital, they prescribed to their coronavirus patients the antibiotic azithromycin along with zinc to increase its effectiveness, while patients with asthma were also prescribed Singulair (montelukast), which has anti-inflammatory properties.
“Dr. Gastaldi added that he prescribed this combination to over 200 patients. Statistically, among them he would have had at least 2 deaths and 40 hospitalizations. However, he explains that he had only two serious cases that required hospitalization and have since been discharged.
“These encouraging results are reinforced by the diversity of his clientele of all ages and some with risk factors. One of Dr. Gastaldi colleagues, Dr. Erbstein, also stressed that none of his patients required hospitalization and so far none have died.”
This article in French provides the source material used for the Gilmore Health article:
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
COVID-19 Thread 4/18/2020 (French Doctors Treating with Azithromycin and Zinc)
Here’s an article about three French doctors treating COVID-19 patients with a combination of azithromycin and zinc.
“Inspired by Previous work on the combination of hydrochloroquine and azithromycin, three doctors practicing in the Moselle in northern France have tested a new treatment on hundreds of patients. Not able to prescribe chloroquine which can only be prescribed in hospital, they prescribed to their coronavirus patients the antibiotic azithromycin along with zinc to increase its effectiveness, while patients with asthma were also prescribed Singulair (montelukast), which has anti-inflammatory properties.
“Dr. Gastaldi added that he prescribed this combination to over 200 patients. Statistically, among them he would have had at least 2 deaths and 40 hospitalizations. However, he explains that he had only two serious cases that required hospitalization and have since been discharged.
“These encouraging results are reinforced by the diversity of his clientele of all ages and some with risk factors. One of Dr. Gastaldi colleagues, Dr. Erbstein, also stressed that none of his patients required hospitalization and so far none have died.”
This article in French provides the source material used for the Gilmore Health article:
http://www.leparisien.fr/societe/sante/coronavirus-trois-medecins-generalistes-pensent-avoir-trouve-un-possible-remede-13-04-2020-8298963.php